Los Angeles Capital Management LLC Viking Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $27.9 Billion
- Q2 2024
A detailed history of Los Angeles Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 12,278 shares of VKTX stock, worth $772,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,278
Previous 11,906
3.12%
Holding current value
$772,777
Previous $976,000
33.4%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$379 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$322 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$142 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$117 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.83B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...